Patents by Inventor Ane Eriksen
Ane Eriksen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12274782Abstract: The present invention relates cannabinoid chewing gums with improved flavor perception. The cannabinoid chewing gums include water-soluble chewing gum ingredients and water-insoluble gum base, one or more cannabinoids with an off-note taste, one or more high intensity sweeteners in an amount of 0.05 to 0.9% by weight of the cannabinoid chewing gum that partly serves to mask the taste of said unbound cannabinoids, one or more flavoring ingredients in an amount of 0.01 to 5% by weight of the cannabinoid chewing gum that in combination with the one or more high intensity sweeteners partly serves to mask the taste of said unbound cannabinoids, wherein the one or more cannabinoids is located in close proximity with the one or more high intensity sweeteners as well as the one or more flavoring ingredients.Type: GrantFiled: June 29, 2022Date of Patent: April 15, 2025Assignee: NORDICCAN A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20240065972Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum including water-soluble chewing gum ingredients and water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the water-soluble chewing gum ingredients include one or more sugar alcohols in an amount of 35-80% by weight of the chewing gum, and wherein the chewing gum has one or more cannabinoids.Type: ApplicationFiled: October 20, 2023Publication date: February 29, 2024Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20240065973Abstract: A tableted chewing gum composition for oral administration of cannabinoids includes a plurality of particles, including a first population of particles having water-insoluble gum base and a second population of particles having water-soluble chewing gum ingredients. The composition constitutes at least two layers, where a first layer of the composition has water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, has water-soluble chewing gum ingredients. The second layer is free of water-insoluble gum base, and the composition includes one or more cannabinoids.Type: ApplicationFiled: October 24, 2023Publication date: February 29, 2024Applicant: NordicCan A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11903919Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: GrantFiled: February 18, 2021Date of Patent: February 20, 2024Assignee: NordicCan A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
-
Patent number: 11833117Abstract: A tableted chewing gum composition for oral administration of cannabinoids includes a plurality of particles, including a first population of particles having water-insoluble gum base and a second population of particles having water-soluble chewing gum ingredients. The composition constitutes at least two layers, where a first layer of the composition has water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, has water-soluble chewing gum ingredients. The second layer is free of water-insoluble gum base, and the composition includes one or more cannabinoids.Type: GrantFiled: August 27, 2020Date of Patent: December 5, 2023Assignee: NordicCan A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11826463Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum including water-soluble chewing gum ingredients and water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the water-soluble chewing gum ingredients include one or more sugar alcohols in an amount of 35-80% by weight of the chewing gum, and wherein the chewing gum has one or more cannabinoids.Type: GrantFiled: September 29, 2021Date of Patent: November 28, 2023Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11471405Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein the chewing gum composition comprises one or more cannabinoids, and wherein the chewing gum composition generates saliva and delivers more than 20% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.Type: GrantFiled: March 1, 2019Date of Patent: October 18, 2022Assignee: NordicCan A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20220323349Abstract: The present invention relates cannabinoid chewing gums with improved flavor perception. The cannabinoid chewing gums include water-soluble chewing gum ingredients and water-insoluble gum base, one or more cannabinoids with an off-note taste, one or more high intensity sweeteners in an amount of 0.05 to 0.9% by weight of the cannabinoid chewing gum that partly serves to mask the taste of said unbound cannabinoids, one or more flavoring ingredients in an amount of 0.01 to 5% by weight of the cannabinoid chewing gum that in combination with the one or more high intensity sweeteners partly serves to mask the taste of said unbound cannabinoids, wherein the one or more cannabinoids is located in close proximity with the one or more high intensity sweeteners as well as the one or more flavoring ingredients.Type: ApplicationFiled: June 29, 2022Publication date: October 13, 2022Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11406593Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum includes water-soluble chewing gum ingredients and water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the chewing gum includes one or more high intensity sweeteners in an amount of 0.01 to 1% by weight of the chewing gum, and wherein the chewing gum has one or more cannabinoids.Type: GrantFiled: January 25, 2019Date of Patent: August 9, 2022Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20220110912Abstract: The present invention relates to a lozenge composition for controlled release of cannabinoids containing i) a master granule component including one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component that includes one or more extragranular sugar alcohols.Type: ApplicationFiled: December 22, 2021Publication date: April 14, 2022Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11253473Abstract: The present invention relates to a method of producing a tableted chewing gum composition for oral administration of cannabinoids, the method comprises the steps of: i) feeding a gum composition comprising water-insoluble gum base into an extruder from one or more feeding inlets, optionally including additional ingredients, ii) pressurizing the gum composition in the extruder while controlling temperature and pressure of the gum composition, optionally including further ingredients from one or more feeding inlets, iii) extruding the gum composition through a die means, iv) cutting the extruded gum composition in a liquid filled chamber, thereby obtaining a first population of particles comprising water-insoluble gum base, v) including the first population of particles with a second population of particles comprising water-soluble chewing gum ingredients and one or more cannabinoids, the second population of particles being free of water-insoluble gum base, thereby obtaining a chewing gum composition and vi) tType: GrantFiled: March 1, 2019Date of Patent: February 22, 2022Assignee: NORDICCAN A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11241413Abstract: The present invention relates to a lozenge composition for controlled release of cannabinoids comprising; i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.Type: GrantFiled: April 17, 2020Date of Patent: February 8, 2022Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20220016024Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum including water-soluble chewing gum ingredients and water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the water-soluble chewing gum ingredients include one or more sugar alcohols in an amount of 35-80% by weight of the chewing gum, and wherein the chewing gum has one or more cannabinoids.Type: ApplicationFiled: September 29, 2021Publication date: January 20, 2022Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11191720Abstract: A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the chewing gum has one or more cannabinoids, and wherein the chewing gum generates saliva and delivers at least 10% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.Type: GrantFiled: January 25, 2019Date of Patent: December 7, 2021Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11166910Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum including water-soluble chewing gum ingredients and water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the water-soluble chewing gum ingredients include one or more sugar alcohols in an amount of 35-80% by weight of the chewing gum, and wherein the chewing gum has one or more cannabinoids.Type: GrantFiled: January 25, 2019Date of Patent: November 9, 2021Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 11154496Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the one or more elastomer plasticizers includes one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the chewing gum has one or more cannabinoids.Type: GrantFiled: January 25, 2019Date of Patent: October 26, 2021Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20210267933Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: ApplicationFiled: February 18, 2021Publication date: September 2, 2021Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
-
Patent number: 11013685Abstract: A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the gum base includes one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the chewing gum includes one or more cannabinoids, and wherein the release rate of the one or more cannabinoids is at least 10% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.Type: GrantFiled: January 25, 2019Date of Patent: May 25, 2021Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 10933017Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein a first population of particles comprises water-insoluble gum base, including one or more polyvinyl acetate elastomer plasticizers, and a second population of particles comprises water-soluble chewing gum ingredients, the second population of particles being free of water-insoluble gum base, wherein the chewing gum composition comprises one or more cannabinoids.Type: GrantFiled: March 1, 2019Date of Patent: March 2, 2021Assignee: NORDICCAN A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Patent number: 10925853Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: GrantFiled: April 17, 2019Date of Patent: February 23, 2021Assignee: NORDICCAN A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff